Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of mean serum vitamin D level among inactive SLE, active SLE without lupus nephritis and active SLE with lupus nephritis

View through CrossRef
Objectives: The primary objective of this study is to compare mean serum 25OHD in SLE patients with inactive disease, SLE patients with active disease but no LN and SLE patients with active disease and LN. The secondary objective is to determine clinical predictors of vitamin D deficiency in SLE patients. Methods: This prospective study included 108 SLE patients. Patients were classified as Group(Gr) 1,2 and 3 if the patients had SLE disease activity index2K(SLEDAI) <3, ≥3 but no LN and ≥ 3 with LN. Serum 25OHD was measured by HPLC method. Results: Mean(SD) age and disease duration of patients was 35.2(11.1) and 7.9(8.3) years respectively. Mean SLEDAI in Gr1, Gr2, Gr3 was 0.7(0.9), 5.6(2.3) and 9.2(5.2) respectively. 47/108(43.5%) had vitamin D insufficiency(25OHD<30ng/ml) and 32/108(29.6%) had vitamin D deficiency(25OHD<20ng/ml). Mean 25OHD in each groups were 28.3(7.1), 26.7(9.5) and 19.9(7.6) ng/ml respectively. Patients with LN had significantly lower 25OHD than other groups (p=0.001). Serum 25OHD was significantly correlated with serum albumin(r=0.32, p=0.001), inversely correlated with SLEDAI(r=-0.30, p=0.002) and inversely correlated with UPCI(r=-0.39, p=0.001). Only UPCI was significantly inversely correlated with serum 25OHD with unstandardized coefficient -1.05(0.38) (p=0.007). Conclusion: SLE patients with LN have significantly lower vitamin D level than inactive SLE and active SLE without LN. Only UPCI is inversely correlated with 25OHD level.
Office of Academic Resources, Chulalongkorn University
Title: Comparison of mean serum vitamin D level among inactive SLE, active SLE without lupus nephritis and active SLE with lupus nephritis
Description:
Objectives: The primary objective of this study is to compare mean serum 25OHD in SLE patients with inactive disease, SLE patients with active disease but no LN and SLE patients with active disease and LN.
The secondary objective is to determine clinical predictors of vitamin D deficiency in SLE patients.
Methods: This prospective study included 108 SLE patients.
Patients were classified as Group(Gr) 1,2 and 3 if the patients had SLE disease activity index2K(SLEDAI) <3, ≥3 but no LN and ≥ 3 with LN.
Serum 25OHD was measured by HPLC method.
Results: Mean(SD) age and disease duration of patients was 35.
2(11.
1) and 7.
9(8.
3) years respectively.
Mean SLEDAI in Gr1, Gr2, Gr3 was 0.
7(0.
9), 5.
6(2.
3) and 9.
2(5.
2) respectively.
47/108(43.
5%) had vitamin D insufficiency(25OHD<30ng/ml) and 32/108(29.
6%) had vitamin D deficiency(25OHD<20ng/ml).
Mean 25OHD in each groups were 28.
3(7.
1), 26.
7(9.
5) and 19.
9(7.
6) ng/ml respectively.
Patients with LN had significantly lower 25OHD than other groups (p=0.
001).
Serum 25OHD was significantly correlated with serum albumin(r=0.
32, p=0.
001), inversely correlated with SLEDAI(r=-0.
30, p=0.
002) and inversely correlated with UPCI(r=-0.
39, p=0.
001).
Only UPCI was significantly inversely correlated with serum 25OHD with unstandardized coefficient -1.
05(0.
38) (p=0.
007).
Conclusion: SLE patients with LN have significantly lower vitamin D level than inactive SLE and active SLE without LN.
Only UPCI is inversely correlated with 25OHD level.

Related Results

VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
Objective: To demonstrate vitamin D deficiency in the general population of Punjab Study Design: Observational, Cross-Sectional Place and Duration: Multicentre study co...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract Introduction Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Precision medicine and patient perspectives in systemic lupus erythematosus
Precision medicine and patient perspectives in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) with diverse clinical presentations and complex immunopathogenesis. Its chronic and variable co...
Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare
Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare
Aim of the study: This study aimed to assess correlation of urinary monocytic chemoattractant protein-1 (UMCP-1) with severity of lupus nephritis and its role as predictor of outco...
P0080INTERLEUKIN-17A GENE POLYMORPHISM (RS2275913G&gt;A) IN SLE PATIENTS
P0080INTERLEUKIN-17A GENE POLYMORPHISM (RS2275913G&gt;A) IN SLE PATIENTS
Abstract Background and Aims There are six IL-17-family ligands [IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (IL-25) and IL-17F]. Int...
Biomarker discovery in systemic lupus erythematosus: genome-methylation approaches : Research report
Biomarker discovery in systemic lupus erythematosus: genome-methylation approaches : Research report
Discovery of novel biomarkers in lupus nephritis Biomarkers are needed for making diagnosis and prognosis. In lupus nephritis, conventional tests like urinalysis or serum creatinin...
Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis
Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis
Background Lupus nephritis (LN) is a major issue that adds a burden on patients with systemic lupus erythematosus (SLE). Immunoglobulin-binding protein 1 (IGBP1...

Back to Top